Dr. Maldarelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Mt Sinai Sch of Med of the City U of NY
New York, NY 10029
Education & Training
Icahn School of Medicine at Mount SinaiClass of 1985
National Institutes of Health Clinical CenterFellowship, Infectious Disease
Certifications & Licensure
NY State Medical License 1987 - 2019- American Board of Internal Medicine Internal Medicine
Clinical Trials
- HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART) Start of enrollment: 2002 Jul 26
- Analysis of HIV-1 Replication During Antiretroviral Therapy Start of enrollment: 2008 Nov 17
- Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy Start of enrollment: 2011 Feb 11
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsLow-level alternative tRNA priming of reverse transcription of HIV-1 and SIV in vivo.Christine M. Fennessey, Celine Camus, Taina T. Immonen, Carolyn Reid, Frank Maldarelli
Retrovirology. 2019-04-04 - 8 citationsA 28-Year History of HIV-1 Drug Resistance and Transmission in Washington, DC.Keylie M. Gibson, Margaret C. Steiner, Seble Kassaye, Frank Maldarelli, Zehava Grossman
Frontiers in Microbiology. 2019-03-08 - 58 citationsMetagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency.Diana V. Pastrana, Alberto Peretti, Nicole L. Welch, Cinzia Borgogna, Carlotta Olivero
Msphere. 2018-12-12
Press Mentions
First Documented Case of Child Cured of HIVMarch 3rd, 2013- Links Between XMRV and Human Disease StudiedOctober 15th, 2010
Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir with Once-Weekly Isoniazid and RifapentineJuly 2nd, 2018
Grant Support
- Role Of Specific Drugs And Mutations In Partial Suppression Of ViremiaNational Cancer Institute2010–2011
- Replication Dynamics In Patients On Suppressive Antiretroviral TherapyNational Cancer Institute2010–2011
- HIV-1 Genetic Variation In Infected IndividualsNational Cancer Institute2010–2011
- Detection And Analysis Of Mouse Retroviruses In HumansNational Cancer Institute2010–2011
- Appearance And Disappearance Of Drug Resistance MutationsNational Cancer Institute2010–2011
- Role Of Specific Drugs And Mutations In Partial Suppression Of ViremiaDivision Of Basic Sciences - Nci2009
- Replication Dynamics In Patients On Suppressive Antiretroviral TherapyDivision Of Basic Sciences - Nci2009
- HIV-1 Genetic Variation In Infected IndividualsDivision Of Basic Sciences - Nci2009
- Appearance And Disappearance Of Drug Resistance MutationsDivision Of Basic Sciences - Nci2009
- Role Of Specific Drugs And Mutations In Partial Suppression Of ViremiaNational Cancer Institute2007–2008
- Replication Dynamics In Patients On Suppressive Antiretroviral TherapyNational Cancer Institute2007–2008
- HIV-1 Genetic Variation In Infected IndividualsNational Cancer Institute2007–2008
- Appearance And Disappearance Of Drug Resistance MutationsNational Cancer Institute2007–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
